When Do We Decide That Generic and Brand-Name Drugs Are Clinically Equivalent? Perfecting Decisions With Imperfect Evidence
- PMID: 28974513
- DOI: 10.1161/CIRCOUTCOMES.117.004158
When Do We Decide That Generic and Brand-Name Drugs Are Clinically Equivalent? Perfecting Decisions With Imperfect Evidence
Keywords: Editorials; candesartan; drug substitution; hospitalization; losartan; valsartan.
Comment on
-
Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series Analysis.Circ Cardiovasc Qual Outcomes. 2017 Oct;10(10):e003891. doi: 10.1161/CIRCOUTCOMES.117.003891. Circ Cardiovasc Qual Outcomes. 2017. PMID: 28974512
Similar articles
-
Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series Analysis.Circ Cardiovasc Qual Outcomes. 2017 Oct;10(10):e003891. doi: 10.1161/CIRCOUTCOMES.117.003891. Circ Cardiovasc Qual Outcomes. 2017. PMID: 28974512
-
Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers.Drugs R D. 2020 Jun;20(2):135-145. doi: 10.1007/s40268-020-00307-2. Drugs R D. 2020. PMID: 32342284 Free PMC article.
-
Taste acceptability of pulverized brand-name and generic drugs containing amlodipine or candesartan.Int J Pharm. 2014 Jul 1;468(1-2):196-8. doi: 10.1016/j.ijpharm.2014.04.035. Epub 2014 Apr 16. Int J Pharm. 2014. PMID: 24746411 Clinical Trial.
-
Generic drugs in dermatology: part II.J Am Acad Dermatol. 2012 Mar;66(3):353.e1-15; quiz 367-8. doi: 10.1016/j.jaad.2011.11.945. J Am Acad Dermatol. 2012. PMID: 22342022 Review.
-
The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.Expert Opin Pharmacother. 2009 Oct;10(14):2317-28. doi: 10.1517/14656560903140525. Expert Opin Pharmacother. 2009. PMID: 19663636 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
